Picture of Nanexa AB logo

NANEXA Nanexa AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Nanexa AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-21.7-35.8-58-76.6-26.1
Depreciation
Non-Cash Items5.217.470.00145.8-0.407
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.2873.2339.6-26.1-10.8
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-16.8-25.1-7.87-42.7-26.4
Capital Expenditures-20.8-25.8-35.4-34.2-28.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.001000.001
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-20.8-25.8-35.4-34.2-28.1
Financing Cash Flow Items-6.55-20.4-1.14-12.30
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities38.914418.860.9-0.327
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.3193-24.5-16-54.9